Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Present from Expanding Neuroscience Portfolio Epidiolex (cannabidiol) Oral Solution Data at the 2021 American Epilepsy Society Annual Meeting
Data from six abstracts advancing cannabidiol (CBD) research to be presented, including two abstracts which highlight results from a U.S. caregiver survey that provides insight on real-world